Technology & AI
Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA
Source: Ars Technica - All content · Published

Anti-vaccine Health Secretary Robert F. Kennedy has unilaterally passed a rule that will allow specialty pharmacies to sell six specific peptide drugs, overruling scientists at the Food and Drug Administration. The peptides are popular among members of Kennedy's Make America Heal
Anti-vaccine Health Secretary Robert F. Kennedy has unilaterally passed a rule that will allow specialty pharmacies to sell six specific peptide drugs, overruling scientists at the Food and Drug Administration. The peptides are popular among members of Kennedy's Make America Health Again movement and many prominent MAHA figures and Kennedy allies sell them.
Kennedy said he uses some of the peptides and called himself a "big fan." But FDA scientists continue to say there is insufficient evidence to show if they're effective and they are potentially dangerous. In 2023, the safety concerns led the FDA to remove the six peptides from a list of drugs that can be made by specialty pharmacies called compounding pharmacies—which make customized formulations of drugs for patients, or, in cases such as this, specialty drugs in bulk. Kennedy's new rule sidesteps the need to formally undo that FDA action.
The rule is titled "Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances" and was made available Wednesday on the Federal Register , with the final publication data set for October 30. The rule does not change the regulatory status of the peptide; instead, it states the Department of Health and Human Services (HHS) will no longer take enforcement action against compounding pharmacies for making the peptides, essentially giving them a green light to freely produce and sell them. Kennedy had quietly proposed this rule earlier this month.
Read full article Comments
Related stories
Breakthrough PTSD treatment achieves 68% remission rate in clinical trial
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the
All Top News -- ScienceDaily ·

Details of thousands of US immigration agents leaked in major hack
A group called the Department of Peace released information on more than 41,000 DHS staff.
feeds.bbci.co.uk ·

Microsoft profits soar days after announcing thousands of layoffs
The week, the Windows developer said it would offer buyouts to 60,000 workers as it looks to curb costs.
feeds.bbci.co.uk ·
Upwind raises $400M after walking away from Datadog acquisition offer
The cloud security startup raised a Series C at a $3.8B valuation, instead of selling itself for the same price.
TechCrunch ·

FCC chair wants to let prisons jam illegal cellphones
The agency will vote next month on relaxing its long-standing opposition to jammers.
Engadget - Technology News & Expert Reviews ·